WallStSmart
CRDL

Cardiol Therapeutics Inc Class A

NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.38
+5.34% today

Updated 2026-04-30

Market cap
$156.35M
P/E ratio
P/S ratio
1,014.87x
EPS (TTM)
$-0.29
Dividend yield
52W range
$1 – $2
Volume
0.8M

Cardiol Therapeutics Inc Class A (CRDL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+22.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+48.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.0%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+4.4%
2026-04-01
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$-0.05+37.5%$1.35$1.41+4.4%
2025-12-31$-0.07+36.4%$0.97$0.99+2.7%
2025-11-18$-0.09-10.6%$0.98$1.00+1.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.08$-0.05+37.5%
2025-12-31$-0.11$-0.07+36.4%
2025-09-30$-0.08$-0.09-10.6%
2025-06-30$-0.10$-0.07+27.6%
2025-03-31$-0.08$-0.10-25.0%
2024-12-31$-0.12$-0.09+22.9%
2024-09-30$-0.08$-0.18-125.0%
2024-06-30$-0.13$-0.10+23.1%
2024-03-31$-0.12$-0.12+0.0%
2023-12-31$-0.09$-0.09+0.0%
2023-09-30$-0.12$-0.09+25.0%

Frequently asked questions

Has Cardiol Therapeutics Inc Class A beaten earnings estimates?
Cardiol Therapeutics Inc Class A has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +22.7% over the last 4 quarters.
How does CRDL stock react to earnings?
CRDL stock has moved an average of +3.0% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.